The FIVB, the World Anti-Doping Agency (WADA) and beach volleyball player Kristen Nuss Cruz have signed a case resolution agreement according to which Ms. Nuss Cruz admitted that the prohibited substance Canrenone was found in her sample collected in-competition on 27 January 2023 during the 2023 Beach Pro Tour Elite16 in Doha, Qatar.
The prohibited substance was found in the Athlete’s system due to her use of a prescribed medication for a medical condition, for which she failed to file a timely Therapeutic Use Exemption (TUE) application.
Ms. Nuss Cruz admitted that she committed an anti-doping rule violation under Article 2.1 and/or Article 2.2 of the FIVB Medical and Anti-Doping Regulations 2022. As a result, she has been sanctioned with a period of ineligibility of two (2) months commencing on 8 September 2026.
The FIVB is committed to protecting fair play and clean athletes and maintains a zero-tolerance approach to doping.
